Onvansertib
22-008
Phase 2 small_molecule active
Quick answer
Onvansertib for Breast Cancer is a Phase 2 program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cardiff Oncology
- Indication
- Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active